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ABSTRACT 
Secondary N-nitrosamines: diphenylnitrosamine (DPhNA), dimethyl-
nitrosamine (DMNA), diethylnitrosamine (DENA), dipropylnitrosamine 
(DPNA), dibutylnitrosamine (DBNA), diethanolnitrosamine (DEtNA), methyl-
nitrosoglycine (MNGly), nitrosopyrrolidine (NPyr), nitrosomorpholine 
(NMor) and nitrosopiperidine (NPip) were synthesised and their' 
interaction with acetylcholinesterase (AChE) was investigated. 
Analyses of kinetic results show that DMNA (Ki=34.78 ~M); DENA 
(Ki=54.24 ~M); DPNA(Ki=60.36 ~M); DBNA(Ki=95.54 ~M); DEtNA(Ki=43.68 ~M) 
MNGly (Ki=30.18 ~M); NPip (Ki=123 ~M); NPyr (Ki=66.07 ~M), 
NMor (Ki=73.93 ~M) and DPhNA (Ki=20.32 ~M) are competitive and 
reversible inhibitors of acetylcholinesterase, with respect to the 
substrate, acetylthiocholine chloride, ATChCl • With time they act as 
irreversible covalent inhibitors with dipropy1nitrosamine producing 72% 
inactivation after 60 minutes. 
Scatchard analyses of f1uorometric titrations, (Kd=0.75mM-4.09mM); gel 
chromatography (Kd=O. 80mM-4. 60mM) and equil ibrium dia 1ysi s (Kd=O. 71mM-
4.21mM) for MNG1y, DMNA, DEtNA, DENA, DPNA, NPyr, DSNA, NMor and NPip 
show that these compounds have weaker affinity for the enzyme, as 
coapared to the much tightly binding aromatic DPhNA, Kd values (0.65mM, 
0.68mM and 0.68mM) for fluorometric experiments, gel chromatography and 
equilibrium dialysis respectively. In all cases, the number of binding 
sites of acetylcholinesterase averaged to four. 
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CHAPTERl INTRODUCfION 
1.1 HISTORICALPERSPECI1VES 
The discovery of the first soluble extract of acetylcholinesterase 
[Acetylcholine hydrolase, EC 3.1.1.7, AChE ] from the electric eel 
Electrophorus electricus and from the electric organ of the ray Torpedo 
IllaT'llOrata was obtained in 1938 (1,2,3). An early review on 
acetylcholinesterase by Nachmanson and Wilson (cited in 1) actually 
opened further avenues into the study of the enzyme. This was followed 
by Silman et at (4) who further confirmed that large quantities of the 
enzyme are readily obtainable from the electric organs of the ray and 
the eel. 
1.2 LOCAllTlES OFAChE 
Experimental findings indicate that AChE is a widely distributed 
enzyme found in a variety of organs: present particularly in excitable 
tissues such as nerve(5,6), muscle, electrogenic tissue (7), human serum 
(8), motor cortex (9), foetal human tissues (10), foetal bovine serum 
(11), basal ganglia (12). Furthermore, it is also found in non-excitable 
tissues such as the surface of the red blood cell membrane (13,14) and 
cobra venom (11,15) as well as in Golgi apparatus (16). From the highly 
specialised organs of Electrophorus electricus and Torpedo marmorata, 
the enzyme was first extracted, solubilised, purified extensively and 
then finally obtained in a homogeneous form and ultimately was 
crystallised (1,3,17). Despite the fact that Electrophorus and Torpedo 
are the rich sources of AChE, it is realised that the electric organ of 
Electricus contains exclusively An forms, while that of Torpedo contains 
both An and Gn forms alongside each other (1,2,18). 
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1. 3 STRUCTURE OF AChE 
Studies on the molecular structure of AChE are of great importance, 
not only for elucidating the mechanism of action of the enzyme, but also 
clarifying the nature of its association with the excitable membrane, 
which is a necessary condition for proper understanding in the way the 
enzyme fulfills Us biological role · in situ. Numerous studies on the 
molecular structure of the enzyme have been reported in the literature 
(7 ,18,19). These indicate that AChE obtained from various sources was 
found to consist of several components which could be distinguished by 
their sedimentation coefficients . in glucose (7).The distribution of 
these IIOlecular forms differs from tissue to tissue, even within the 
Sdllle animal (lS). These molecular components were further found to 
differ in their quaternary structure and solubility characteristics. 
They are conveniently classified according to the nomenclature of Bon et 
aJ. (20,21) as "asymmetric" (An) and "globular" (Gn) formms of n 
catalytic subunits. [See FIGURES l{a) and l{b)]. 
The An forms are elongated structures of AChE and are localized 
primarily at skeletal neuromuscular junctions, which appears to be 
mediated by the interaction of the . collagen-like tail structure with 
extracellular basement membrane (13). In these forms, a large head is 
connected to a fibrous tail of about 500nm in length (4,7,17) • This 
multisubunit head is found to contain one, two or three catalytic 
subunit tetramers designated A4, As, and A12 respectively. The role of 
the tail is to anchor the enzyme to the basal lamina within the synaptic 
cleft (lS). 
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a II 
• .. • 
b As~~tr~ IA12) F~m Globular IG 4) Form 
s-s 
FIGURE 1 : Schematic representation of (a) asymmetric and globular forms of acetylcholinesterase 
(AChE), and (b) their interconnection by disulphide bonds (18,22). 
The detailed studies substantiated the contention that the fibrous tail 
is collagenous in nature, and this led to the model shown in FIGURE 2. 
505----+ 
TRYPSIN 
PEPSIN 
COLLAGENASE 
FIGURE 2:Schematic representation of A 12 form of AOJE from Electrophorus electricus (18). 
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In FIGURE 2, the arrows show the points of cleavage by proteases and by 
sodium dodecyl sulphate (SOS). Three cat a lytic subunit tetramers are 
connected via disulphide linkages to a collagen triple helix; the 
corresponding A4 and AS forms, present in smaller amounts, contain one 
and two subunit tetramers respectively, similarly connected to the tail 
structure (7,19). 
Properties of the asymmetric forms have been established. Sucrose 
gradient centrifugation studies show that A4, AS and A12 sedimented as 
SS, 11S and lSS respectively (1). The three species from eel have been 
5 
purified and appear in electron micrographs as clusters of 4, 6-8 and 10 
respectively, or more subunits attached to an elongated "tail" (1) 
[FIGURE 3]. 
c o 
FIGURE 3 :Electron micrographs o/various molecular/orms of AChEfrom eel electric organ obtained by 
negative staining (1). 
In FIGURE 3: (A) shows 145 and 185 species characteristic of highly 
purified preparation obtained directly from fresh tissue extracts. The 
field also contains multisubunit "heads" connected to "tails" and 
separated "tails", magnified 340 000 times, (8) shows a single molecule 
of 115 species magnified 650 000 times; (e) shows a single molecule of 
85 species magnified 600 000 times and (D) is a single molecule of 185 
species, magnified 600 000 times. 
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All three of these asymmetric species may be converted to a globular 11S 
form by treatment with trypsin, sonication or by allowing ageing (3). 
The resu lts of electron micrographs of 18S AChE strongly suggest that 
this molecule contains three sets of subunit tetramers (1), and that the 
tail of the enzyme is composed of three individual filaments, and each 
associated with one tetramer, and intertwined in the distal portion of 
the strand. On the other hand, globular forms of acetylcholinesterase 
appear to be widely distributed on the outer surface of the membranes 
, 
(2). These forms consist of monomers, dimers or tetramers of the 
catalytic subunit and are designated G1, G2 and G4 respectively . Both 
G2 and G4 are recorded to sediment to 8S and 11S respectively (1). These 
forms can further be subdivided into two groups: (a) those that interact 
with nonionic detergents following extraction, and presumably correspond 
to integral membrane proteins in situ, and (b) those that do not bind 
detergent and are presumed to be soluble proteins (13,23,). Thus Gn 
forms are either hydrophobic or non-hydrophobic. Hydrophobic AChE has 
also been purified to homogeneity from the brains of a number of 
vertebrate species such as bovine, rat, human and chicken. In all these 
cases the purified brain enzyme occurs as a G4 tetramer(18). 
Furthermore, the water-soluble Gn forms in some cases are found to be 
"lytic" species derived from either the An forms or from the hydrophobic 
Gn forms by endogenous or exogenous removal of the membrane-anchoring 
domain (8,9). Evidence is available (18,19,24) that hydrophobic AChE is 
linked through other proteins to the plasma membrane [FIGURE 4]. 
Phosphatidylinositol is attached via a glycosidic linkage to a 
glucosamine residue, while the latter is attached to an oligoglycan 
(23). 
ACHE 
CATALYTIC 
SUBUNIT 
-_/'"-s-S 
C-TERMINAL AMINO ACID 
ETHANOUMlNE 
GLYCAN 
GLUCOSAMINE 
INOSITOL 
OUTER FACE 
MEMBRANE 
INNER FACE 
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FIGURE 4:A model of the membrane-anchoring domain of the hydrophobic G2 form of AChE from 
Topedo califomica (18). 
1.3.1 Molecular Architecture of the Catalytic Site 
The active site of AChE is confirmed to consist of three amino 
acids viz. serine, histidine and aspartic acid that facilitate enzymatic 
catalysis (1,18). Two subsites of the active site that interact with 
cationic substrates and inhibitors have also been identified a 
negatively charged subsite and an esteratic subsite. The latter includes 
the serine hydroxyl, which is the residue presumably acylated or 
deacylated during a catalytic turnover (1,16) [FIGURE 5]. 
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c;r---, N"----H-O ~ ,~ -t l 
Anionic Site Esteratic Site 
FIGURE 5 :Schematic iJ/ustration of the two subsites of acetylcholinesterase and its substrate, 
acetylcholine 
1. 4 FUNCTIONS OF AChE 
Acetylcholine [ACh] whose molecular structure is illustrated in 
FIG.5, is found as a metabolite in high concentrations in nervous tissue 
and in motor nerve tract, as an active neurotransmitter substance. The 
first discovery of the action of this substance came later in 1914 when 
Dale (25) tested the actions of many esters and ethers of choline. When 
a nerve impulse travels down the axon to the synapse, acetylcholine is 
released from nerve endings (26,27), diffuses across the cleft and 
interacts with the postsynaptic receptor on the cell membrane 
(29,30,31). 
Acetylcholinesterase is a principal enzyme in impulse coordination in a 
biological system. Its main biological function is the termination of an 
impulse at cholinergic synapses by rapidly hydrolysing acetylcholine to 
acetic acid and choline (16,32,) according to reaction (1). 
9 
Acetylcholine choline acetic acid 
This enzymatic cleavage lowers the concentration of free acetylcholine 
in the synaptic cleft, and by perturbation of equilibrium, will induce 
dissociation of the acetylcholine-receptor complex , thus directing the 
signal to the muscle cell. 
Active AChE is very crucial in neuromuscular function (33), and 
inhibition of the enzyme results in coordination imbalances, muscle 
paralysis and asphyxiation . Chemical reactions at the junctions between 
cells involved in the signal transmission are facilitated by close 
association between the enzyme and its receptor, viz. nicotinic 
acetylcholine receptor [nAChR] which is located on the postsynaptic 
membrane (34,36). The presence of acetylcholine on the receptor makes 
the latter undergo a conformational change which triggers ion 
permeabil ity by opening a self-contained cation channel (36,37). This 
smooth functional co-operation between AChE and nAChR is ascribed to 
their functional similarites. Structurally they both have an "esteratic" 
and "cationic" subsites in the active sites (38,39,). 
1.5 PROPOSED CATALYTIC MECHANISM OF AO!E 
Kinetic mechanisms for enzyme-catalysed reactions are ordinarily 
proposed to explain initial-rate data (40,41). It was this very sort of 
attempted correlation that led Brown (42) in 1902 to suggest that the 
enzyme and its substrate must combine for a finite period of time 
before catalysis can occur. 
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Subsequently, a large number of cata lyt ic mechani sms {43, 44 ,45,} have 
been proposed to explain the enzyme-substrate interaction at a molecular 
level . Knowledge of the enzyme's kinetic mechanism is important in order 
to understand how the enzyme functions as a biological catalyst, as well 
as how it · is regulated in the cell. This information is not only 
necessary, but also important in order to evaluate inhibition constants 
for multisubstrate enzymes. The establishment of such a mechanism for an 
enzyme may further provide information on, among other things, the 
chemica 1 mechani sm, the nature of the trans ition state (46 ,47), the 
geometry of the active site, substrate specificity, inhibition and 
activation, acidic and basic groups associated with catalysis {47,48}, 
allosteric properties as well as the mode of regulation at the 
physiological level {49,50,51}. The catalytic reaction of AChE involves 
a double displacement mechanism with a nucleophilic serine at the 
anionic site with cationic center of the substrates and inhibitors 
{42,52}. 
Firstly, an acyl-enzyme is formed . This bears the acetyl group of serine 
residue of the active site. Secondly, the acyl-enzyme is then hydrolysed 
off. One such feature is the fact that serine proteases have an 
evolutionary conserved "catalytic triad" of sedne, histidine and 
aspartate originally called the 'charge relay' system {53,54}. The 
chemically inactive hydroxyl group of serine is activated with the aid 
of imidazole group of histidine located in its immediate vicinity 
{32,54,55} [SCHEME 1]. On interaction with the substrate, the activation 
process begins with the formation of a hydrogen bond between its 
carboxyl oxygen and the imino-nitrogen of the imidazole, which increases 
the basicity of the azole nitrogen and leads to the formation of 
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hydrogen bond between this nitrogen and the serine hydroxyl moiety. 
There is then a sharp increase in the nucleophilicity of the hydroxyl 
oxygen and its interaction with the central carbon atom is facilitated. 
SCHEME 1 : The postulated catalytic mechanism of acetylcholinqterase during its hydrolysis of 
acetylcholine, (ACh) (1). 
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The redistribution of electron density in the eight-membered ring of the 
enzyme-substrate complex formed results in the formation of a covalent 
bond between the serine oxygen and the acid group of the substrate and 
in the elimination of the alcohol group (56,58),the subsequent reaction 
of the acetylated enzyme with water proceeds analogously, forming an 
intermediate acyl-enzyme-hydrate complex which then decomposes to the 
initial enzyme and the acid (1,54,59). In this way, the reactive form of 
serine hydroxyl is regenerated at the instant of the oriented binding of 
• 
the substrate molecule, (60,61) [SCHEME 1]. 
1.6 INHIBmONSTUDIESONAChE 
With the molecular studies of AChE, and the identification of the 
amino acids involved at the active site, studies on the inhibition of 
this enzyme with both natural and synthet ic cO'llpounds have been well 
documented (62,63). 
Some of the compounds tested include : quaternary derivatives of 
pyridine and acridine (62), 1-bromo-2 pinacolone (63,64), alkylating 
agents, N-dansyl aziridine and S-Mercuric-N-dansylcysteine (65), anionic 
and cationic drugs (66,67), isoquinoline alkaloids (67,68,69), 
phosphorus-containing molecules such as organophophates (70,71,72), 
phosphonate esters (73,74,75), sulphur-containing compounds (76,77,78), 
carbamates (79,80,81), methanesulphonic acid esters (82,83,84), 
substituted ethylenediamines (85), nitro- and nitroso-containing 
substances (86,87), aryl esters and anilides (88), ethanol (89), organic 
acids (90), trimethylammonium bromide (91,92), pyridoxal 5'-phosphate 
(93,94), phosphorylated alkaloids (95), and a host of others (96-99). 
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Generally, inhibition on AChE catalysis occurs on the basis of the 
anionic site binding and orientating substituted ammonium ions, as well 
as the esteratic site, where the hydrolytic processes occur (100,101). 
Reversible inhibitors such as substituted ammonium ions may act, not 
only by competition with the substrate for the active site of the free 
enzyme, but possibly also by combining with the acetyl-enzyme at the 
anionic site [see SCHEME 2]. 
o H,C, / -" 
N O-H 
/+, 
H,C; CH, 
.... -,--~~ .... !:!H~O 
\ 
SCHEME 2:An illustration of an inhibition of AChE by Edrophonium (67). 
Perhaps it should therefore, be easy to imagine that deacylation would 
be sterically blocked, especially if the water molecule had to approach 
from the direction of the anionic site . This restriction on the 
direction of the approaching water molecule is to be anticipated for the 
reason that acetylcholinesterase catalyses the hydrolysis of 
acetylcholine. During the regeneration of acetylcholine, a choline 
molecule attacks the acetyl-enzyme, and this attack comes clearly from 
the direction of the anionic site (100,101). 
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1.7 N-NITROSAMINES AS AChE INHIBITORS 
1.7.1 Properties of N-Nitrosamines 
Nitrosamines are good ligands for proteins involved in , a 
cholinergic system. Like other molecules, nitrosamines are able to 
undergo photolysis, especially in the presence of a dilute acid 
(107,108,109) [SCHEME 3]. 
R 
• 
"-
/
-N-OH + A=o 
R 
ENZ. ALKYLATION 
SCHEME 3:Schematic Representlllion of Photodecomposition of N-Nitrosamine in the presence of a 
diJuU acidic medium. 
This photolability is also closely associated with the polar character 
of the nitrosamine (110,111). An interest ing addi'tio'na 1 feature of these 
molecules is that their [-N=O-] moiety is responsible for their affinity 
and is also the photolabile function (111). Goeldner et al (107) have 
indicated that the nitrosamines were specifically photoactivated after 
association with a proton at the active site . N-nitrosamines are thus 
classified as photoaffinity labels or photosuicide inhibitors (87). By 
definition photoaffinity labels are ligands that have inherent affinity 
for a binding site, and possess biological activity, but also contain a 
photosensitive functional group, which when photoactivated is capable of 
forming a covalent bond at or near the binding site. Their association 
with the recognition site will ordinarily be reversible till photolysis 
is initiated (110,111,112). 
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Furthermore, this specific photoactivation should lead to a highly 
reactive species which can irreversibly modify the protein in the 
vicinity of the active site [SCHEME 4]. 
Arkyl~ling 
spKiu 
PHASE TRANSfER 
COV.l,ren( 
bond 
ENERCY TRANSFER 
SCHEME 4:Schematic iUustrotion of photosuicide labelling of the active site of an enzyme by a 
secondmy nitrosamine (107). 
In SCHEME 4, the energy transfer system involves fluorescent amino acid 
residues, whereby the donor tryptophan (Trp) residues of the protein and 
the acceptor which is a labelling reagent are in close proximity (107). 
Furthermore, the photolabile ligand (L-Y) should be stable at the 
tryptophan excitation wavelength (about 290nm), i.e it must be an 
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efficient quencher; and it must also be photosensitive at tryptophan 
emission wavelength (about 340nm). Nitrosamines according to phase 
transfer induced labelling, will be photoactivated after the association 
with a proton at the active site (107,110). 
Various experimental physical measurements using UV, IR, (111,112) and 
NMR (113,114) spectroscopy have been carried out to study the nature and the 
character of the nitroso funct"iona 1 group (115). Considerable evidenc~ 
gathered indicates the existence of a partial NuN double bond 
character, and the location of the negative pole at the nitroso oxygen. 
It has been established that a proton (or a Lewis acid) would seek the 
oxygen as the co-ordination site (108,110,112) maintaining the secondary 
nitrosamines in two resonant forms: [See also APPENDIX 12] 
This resonance character of the molecule indicates that the structure of 
the secondary nitrosamine is partially planar (115). Furthermore, 
nitrosamines like their respective amines are rich sources of 
carbocations [See APPENDIX 13]. The latter were found to be capable of 
alkylating alcoholic residues on the enzyme Chymotrypsin (87). It is 
thus expected that the generation of such carbonium ions at the active 
site of an enzyme should a lkylate the carboxylate anion of either 
glutamic Dr aspartic acid of the subsite and therefore "labelling" it 
(87,88). 
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1. 7.2 Synthesis 
The following nitrosamines were synthesised: DBNA, DPNA, DMNA, 
DEtNA, NPip, NMor, NPyr, DPhNA and MNGly. Nitrosation of secondary 
amines occurs in a strongly acidic medium, with sodium nitrite as the 
nitrosating agent (103,104). During the generation of a nitroso 
compound, sodium nitrite (NaN02) reacts with strong acid at OOC to 
generate a nitrosyl ion [:N+=O]. The latter is then transferred readily 
to the nucleophilic nitrogen of the secondary amine (103,106) [SCHEME 5] 
HONO + H+ 
R R R ,~ 
'+ \ H+ N-H + :N+=O --. H-N -N=O ..... N-N=O + / / / R R R 
A B C 
SCHEME 5 :Reaction Mechanism for generation of N-Nitrosamine from Secondary amine and 
nitrous acid, where A, B and C are secondary amine, unstable intermediate and secondary 
nitrosamine respectively. 
1.7.3 Proposed Inhibition Mechanism 
It is established that both nitro and nitroso compounds serve as 
reversible competitive inhibitors to AChE (54,87). The canonical form 
R2N=N-0- is important in representing the structure of nitrosamines. The 
barrier rotations about the N-N bond are recorded to be 70-160 KJ.mol-1, 
and the dipole moment (u=4.0 D) (117). 
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It is logical therefore to envisage the blocking of the binding of 
acetylcholine by the nitrosamine bound to the active site of the enzyme. 
The binding of the nitrosamine to the active site of the enzyme is 
considered to be two fold : Firstly, the negatively charged, ionised 
oxygen of the nitroso group will tend to interact with, at least one 
protonated residue in the active site of the enzyme within the enzyme-
substrate complex [SCHEME 7(a)]. Secondly, the active site of AChE must 
have a hydrophobic nature, and to support this idea, at least one 
tryptophan has been shown to be close to the active site (54,63). This 
implies that the nitrosamine passes from a hydrophilic to a hydrophobic 
environment, before it can bind to the enzyme. This change of 
environment is a requisite for effective binding of acetylcholine to the 
active site, and has already been implicated as an important factor in 
enzyme catalysis (54). 
On the validity of these assumptions, the reaction mechanism suggests 
that the starting nitrosamine would decompose, as soon as it reaches the 
active site, into an alkylating species, [R+]. This generation of a 
carbocation occurs according to the following process : 
R 
'\ H-H=O 
/ 
R 
SCHEME 6 : Generation of a caroocation [R + j, during decomposition of a nitrosamine. 
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The released carbocation species [R+] then interacts with serine 
hydroxyl group in an irreversible way (54). In this way, the substrate 
molecule is prevented from binding to the enzyme, according to the 
following simplified reaction 
HO-Ser-ENZ ___ a R-O-Ser-ENZ 
The representation of such an irreversible mechanism is depicted in 
SCHEME 7(b). 
a 
b 
/'7 
,./.R 
N!N..) 
R 
------~. \ 
o 
~ 
SCHEME 7:MecJumism of interaction ofnitrosamine with acetylcholinesterase involving a reversible (a) 
and irreversible (b) competitive inhibition. 
CHAPTER 2 SYNTHESIS OF SECONDARY N-NITROSAMINES 
2.1 MATERIALS and METHODS 
2.1.1 Reagents 
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All the chemical reagents used were of analytical grade. 
Dibutylamine, diphenylamine, dimethylamine, diethylamine, dipropylamine 
were all obtained from Hopkins Williams Chemical Co. UK, pyrrolidine, 
piperidine, morpholine, N-methylglycine and diethanolamine were all 
obtained from Aldrich Chemical Co. All other chemical and solvents as 
well as acids were of reagent grade (Holpro). 
2.1.2 Methods 
General Procedure: 
Secondary amine (0.2Smol) was added slowly to 
hydrochloric acid (SOml,SM), initially cooled in ice at SoC. The 
solution of the amine-acid was then introduced to a solution of sodium 
nitrite (20.70g, 0.30mol) in 2Sml water contained in a 2S0ml distilling 
flask and the mixture azeotropically distilled. The aqueous distillate 
was extracted several times with ether, and the ether layers combined, 
dried (M9504) and the solvent evaporated. Respective nitrosamines were 
purified by flash chromatography or recrystallization (118) [TABLE 1]. 
Diethanolnitrosamine: 
Hydrochloric acid (167ml, 2M) was added slowly to 
a cold solution (lOOC) of diethanolamine (3S.03g, 0.33mol). The 
resulting solution was treated dropwise during one hour with cold (S-
100C) solution of sodium nitrite (27.02g, 0.39mol) in water (3Sml). The 
reaction solution was stirred at 100e for 30 minutes and again at 3SoC 
for one hour then concentrated under reduced pressure at 60oC. The 
residual mixture was stirred in absolute ethanol (SSml), filtered to 
remove the insoluble salts and then evaporated again under reduced 
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pressure. Extraction into ether, filtration and evaporation were 
repeated several times. The organic layer was dried and evaporated to 
produce a yellow oil. Distillation of the residue afforded an oil 
(27.67g, 79%); Bp 110-1190C at 1.0 mmHg (104). 
Diphenylnitrosamine: 
Diphenylamine (2S.39g, O.lSmol) was added in 2S0ml 
of warm ethanol and together with sodium nitrite (22ml, 13.80g, 0.20mol) 
were cooled to below SoC. The solution of diphenylamine-ethanol was 
acidified with hydrochloric acid (2Sml,SM) under slow and constant 
stirring. To this mixture, sodium nitrite solution was rapidly added and 
stirred. The crystals of diphenylnitrosamine were filtered, washed with 
water and recrystallised (petroleum ether) to afford the product 
(17.77g, 70% Mp 67-690C) (102). 
N-Methyl-N-nitrosoglycine: 
Sodium nitrite (13ml, 7.63g, O.Hmol) was 
added dropwise to a hot (9S0 C) solution of N-Methylglycine (8.91g, 
0.10mol) dissolved in hydrochloric acid (SM, Sml). The mixture was 
heated (lh), cooled, and extracted with ether. The ether layers were 
combined,dried (MgS04) and evaporated to afford an oil which 
crystallised on standing. Recrystallisation (ethyl acetate) afforded 
90.S% (8.06g, Mp 74-760 C) (lOS). 
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TABLE 1 : Properties of N-Nitrosamines 
EXPERIMENTAL LITERATURE 
VALUES VALUES 
NITROSAMINE YIELD(%) Mp(OC) Bp(OC) Mp(OC} Bp(OC REF. 
DBNA 78.2 ----- 130-134 ----- 133 102 
DEtNA 79.4 ----- 110-119 ----- 100-120 104 
DENA 80.5 ----- 173-175 ----- 177 102 
DMNA 12.5 ----- 146-148 ----- 149-150 102 
DPhNA 70.5 67-69 ------ 66.00 ----- 102 
DPNA 69.3 ----- 175-178 ----- 176-177 102 
MNGly 90.5 74-76 ------ 75-77 ----- 105 
NMor 81.1 26-30 96-98/1J11l1Hg 29.00 98/1J11l1Hg 102 
NPip 80.1 ---~- 102-114 ----- 100-109 102 
NPyr 69.7 ----- 110-115 ----- 98 102 
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CHAPTER 3 KINETIC STUDIES 
3.1 ASSAYOFACETYLCHOUNESTERASE 
3.1.1 MATERIALS and METHODS 
. 3.1.1.1 Materials 
All the reagents used were of analytical grade. 
Acetylthiocho line chloride (ATCh. Cl) and Ellmans reagent [5, 5-dithiobis-
(2-nitrobenzoic acid)] were obtained from Sigma Chemical Co, . 
NaH2P04.2H20, sodium hydroxide (NaOH), sodium bicarbonate (NaHC03) were 
obtained from BDH Chemicals LTD, Poole, England; Acetylcholinesterase 
(type III, salt free, 100 U/mg lyophilisate from Electrophorus 
electricus) was purchased from Boehringer Mannheim, West Germany. All 
other chemicals were of reagent grade. 
3.1.1.2 Methods 
The colourimetric method (119) was employed. The 
principle involves the hydrolysis of acetylthiocholine chloride by AChE 
to acetic acid and thiocholine according to Reactions (2) and (3): 
(0I3hWCHZCHZSCOCH3 + H20 AChE. (CH3hN+CH2CHZSH + CH3COOH (2) 
Jcety.1thiocho 1 ine thiocholine acetic acid 
+ 
Ol~~-~ tOl 
-oot DTNB 00-
.. . -..... .. (3) 
I 
+ CIN) }s 
-00 
Z-nitrobenzoate-5-mercaptothiocholine 5-thio-2-nitrobenzoate 
The catalytic activity is measured by following the increase of the 
yellow anion, 5-thio-2-nitrobenzoate, produced from thiocholine when it 
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reacts with DTNB (Ellmans reagent) according to reaction (3). The assay 
mixture (3.14ml) contained phosphate buffer (O.IM, pH B.O) buffered 
Ellman.r reagent (10mM), NaHC03 (17.85mM, pH 7.0) and acetylt/liocholine 
chloride (478 ~M). Aliquots were first made up to 3.12ml with phosphate 
buffer (pH 8.0) and the reaction initiated by the addition of 0.02ml of 
acetylcholinesterase [See APPENDIX 9 for Measurements]. The enzyme 
concentration (4.66 ~M) was determined using the absorption coefficient 
(Al%lcm) of 16.1 at 280nm and MR of 260 000 
3.1.2 RESULTS 
... 
I 
:E 
:1. 
. 
c 
-E 
... 
I 
o 
... 
>< 
> 
...... 
... 
18 
2 
Olr-----.-----.-----.-----.-____ .-____ .-__ ~ 
o 5 10 15 20 25 30 35 
l/[ATCh] x 10-3 ~M 
FIGURE 6: Uninhibited hydrolysis of acetylthiocholine chloride (ATa..chloride) by acetylcholinesterase 
(AChE) 
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3.1.3 DISCUSSIDN 
The activity of the enzyme was optimised under the stated 
experimental conditions. The increase in the concentration of the 
substrate resulted in an overall increase in the velocity of the enzyme-
catalysed reaction . However, as the concentration of the substrate was 
increased, a drop in the enzyme velocity was apparent. This could be 
interpreted as being due to "substrate inhibition". From these results 
Vmax and Km were estimated to be 263.16 ~M.min-1 and 1D2.61 ~M 
respectively. 
3.2 INHIBITION STUDIES 
3. 2.1 MATERIALS and METHDDS 
3.2.1.1 Materials 
A 11 the chemicals used were of ana lytica 1 grade. The 
nitrosamines were prepared as described in CHAPTER 2. 
3.2.1. 2 Methods 
Inhibition of acetylcholinesterase by interaction with 
various nitrosamines was studied in the the presence of phosphate buffer 
(0.1M,pH 7.0), acetylthiocholine chloride (0-478 ~M) and a nitrosamine 
(0-320 ~M). Aliquots (2.8ml) were treated with enzyme solution (0.2ml). 
Polyethyleneglycol (2%) was used as a co-solvent for DPhNA. 
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3.2.2 RESULTS 
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FIGURE 7:Competitive inhibition of acetylcholinesterase by dipropyinitrosamine (DPNA) at pH 7.0. 
rate of the enzymatic reaction. The secondary plots represent the slopes of the Lineweaver-Burk lines verms 
DPNA concentration. 
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3.2.2 RESULTS (Contd.) 
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FIGURE 8: Competitive inhibition of acetylcholinesterase by diphenylnitrosamine (DPhNA) at pH 7.0. 
Concentration of DPhNA is (0) 0 IJ.M; (e) 32 IJ.M; (4) 64 IJ.M; (.11.) 160 IJ.M; ~ 320 IJ.M The 
secondary plots represent the slopes of Lineweaver·Burk lines VernIS DPhNA concentrotion. 
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3.2 .2 RESULTS (Contd.) 
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FIGURE 9(a): Competitive inJu"bition of acetylcholinesterase (0), at pH 7.0 by diphenylnitrosamine 
(DPhNA), ()(); methylnitrosoglycine (MNGIy), (. ); dimethylnitrosamine (DMNA), ( .. ); 
diethanolnitrosamine (DEtNA), (f); diethylnitrosamine (DENA), (e ). The concentration of the 
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3.2.2 RESULTS (Contd.) 
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FIGURE 9(b): Competitive inhibition of acetylcholinesterase (0), at pH 7.0 by dipropylnitrosamine 
(DPNA), (11.1; nitrosopynvlidine (NPyr), (e); nitrosomorpholine ((W, ; dibutylnitrosamine (DBNA), ~); 
nitrosopiperidine (NPip), (f). The concentration of the nitrosamines is 3201l-M. 
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3.2.2 RESULTS (Contd.) 
TABLE 2 :Kinetic Constants of nitrosamines as determined from their respective plots 
INHIBITOR CONC. (ILM) KmAPP (IL M) Ki (IL M) 
DPhNA 32 264.20 20.32 
64 425.79 
130 759.07 
160 910.56 
320 1718.52 
MNGly 32 211.41 30.18 
64 320.20 
130 544.60 
160 646.60 
320 1087.98 
DMNA 32 197.02 34.78 
64 292.43 
130 486 .14 
160 574.65 
320 1046.69 
DEtNA 32 177 .78 43.68 
64 252.95 
130 408.00 
160 478.47 
320 854.33 
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3.2.2 RESULTS (contd.) 
TABLE 2 .Kinetic Constanls of nitrosamines as detennined from their respective plots 
INHIBITOR CONC. (".M) KmAPP ( ILK) Ki ( ILM) 
DENA 32 163.15 54.24 
64 223.68 
130 348.54 
160 405.29 
320 707.98 
DPNA 32 157.01 60.36 
64 211.41 
130 323.60 
160 374.60 
320 646.61 
NPyr 32 152.31 66.07 
64 202.00 
130 304.51 
160 351.10 
320 599.58 
NMor 32 147.02 73.93 
64 191.44 
130 283.04 
160 324.68 
320 546.75 
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3.2.2 RESULTS (contd.) 
TABLE 2 Kinetic Constants of nitrosamines as determined from their respective plots 
INHIBITOR CONC.( fl.M) KmAPp( fl.M) Ki ( fl.M) 
DBNA 32 136.98 95.54 
64 171.35 
130 242.23 
160 274.45 
320 446.29 
NPip 32 129.30 123.00 
64 156.00 
130 211.06 
160 236.09 
320 369.56 
3.2.3 DISCUSSION 
The continual addition of different nitrosamines to the enzyme-
catalysed reaction resulted in a decrease of enzyme activity 
These results give evidence of a reversible inhibitory mechanism due to 
the characteristic Lineweaver and Burk (120) plGts [FIGURES 7-9]. This 
further illustrates that all the nitrosamines studied were competitive 
inhibitors of the enzyme with respect to acetylthiocholine chloride . A 
replot of the slopes of the double-reciprocal plot versus ligand 
concentration is linear [FIGS. 7 and 8, inset]. 
The established kinetic constants show an increase in values from 
DPhNA(20.32 fl.M) to NPip{123 fl.M) [TABLE 2]. Kinetic constants indicate 
the extent of inhibition and the degree of association imposed on the 
enzyme by a particular inhibitor. 
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On the other hand, the values increase with an increase in the length of 
the aliphatic (R) chain. This means that the potency of inhibition by 
the nitrosamine decreased with the increase in chain length . 
3.3 TEST OF REVERSIBILITY OF INTERACTION BETWEEN NITROSAMINE AND AChE 
3.3.1 MATERIALS and METHODS 
3.3.1.1 Materials 
All chemical reagents used were of analytical grade. 
Acetylthiocholine chloride, Ellmans reagent, phosphate buffer (0 .1M, pH 
8.0), dialysis membrane (obtained from Spectrophor). 
3 . 3 .1. 2 Met hods 
The test of reversibility of the interaction of a 
nitrosamine with acetylcholinesterase was carried out by dialysis 
(54,69). A mixture of a nitrosamine (32-320 ~M) and the enzyme solution 
(3.0ml) was incubated at room temperature (lhour) . The solution was 
dialysed against deionised water (pH 7.5), at 40C for 48 hours. The 
enzyme activity was determined at the beginning of dialysis, after 24 
and 48 hours . 
34 
3.3.2 RESULTS 
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FIGURE 10: Inactivation of acetylcholinesterase, (Aa.E) by dipropylnitrosamine, (DPNA) at pH 7.0. 
3.3.3 DISCUSSION 
Incubation of acetylcholinesterase with dipropylnitrosamine 
resulted in a progress ive- loss of enzyme activity as depicted in FIG. 
10. These results indicate that the inactivation of the enzyme by DPNA 
was dependent on the concentration of the nitrosamine as well as on the 
incubation time. When the enzyme was mixed with 32 ~M DPNA, 28% of the 
control activity remained after 60 minutes while it took only 6 minutes 
in the presence of 320 ~M DPNA to reach the same activity. 
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CHAYmR4 BINDING STIJDIES 
A thorough understanding of the biochemical significance of a ligand 
which is a small molecule that binds to a macromolecule ego protein or 
enzyme comes only from a quantitative analysis of the strength of 
binding. Binding affinity between two molecules is often expressed in 
tel'llS of an association constant, Ka of the protein-ligand complex 
(121,122). 
In order to make a comprehensive study on the effect of secondary 
nitrosamines on AChE, it thus became one of the aims of this work to 
investigate the binding of these molecules to the active side of the 
enzyme. This objective was accomplished by carrying out the binding 
studies using three techniques: Equilibrium dialysis, Gel chromatography 
and Fluorometry. 
4.1 EQUILIBRIUM DIALYSIS 
4.1.1 MATERIALS and METHODS 
4.1.1.1 Materials 
All chemicals and reagents were of analytical grade. 
Phosphate buffer, deionised water, dialysis tubes were from Spectrophor. 
4.1.1.2 Methods 
The experiments were carried out according to the method 
of McPhie(121). Acetylcholinesterase (15 ~g.ml-l,3.Oml) was dialysed at 
40C against phosphate buffer (20mM, pH 7.6) containing ligand (1.0-
7.5mM,I .Oml) under constant agitation for 24 hours. After equilibrium, 
the concentration of the ligand outside the. dialysis bag was determined 
spectrophotometrically using absorption coefficients (124) [APPENDIX 1]. 
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Data was then analysed according to Scat chard (125), the number of 
binding sites, p and the dissociation constants, Kd determi ned according 
to equations (1) and (2): 
v/ [L]f = p - v / Kd .... (1) t,. Ax / t,. Axmax = v / p • • • • (2) 
where v are the molecules of bound ligand, p is the number of binding 
sites, [L]f is the concentration of free ligand, Kd is the dissociation 
. constant of the ligand-enzyme complex, t,. Ax is the difference in the 
absorbance of the two solutions at wavelength x and t,.Axmax is the 
maximal absorbance change . 
4.1.2 RESULTS 6r-------------------------__ ~ 
5 
....... 
... 4 I 
~ 
....... 
"-,....., 
-' 3 ...... 
--:> 
2 
1 
°Or--------i1---------2~------_+3------~~4~~ 
v 
FIGURE 11(8) :Scatchard plot for binding of DPhNA(cj, MNGIy~, DMNAr,.), DEtNA(o) and DENA(rc) 
to AOtE as determined by equilibrium dialysis, v are molecules of bound ligand. 
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FIGURE 11(b) :Scatchard plot for the binding of DPNA(e), NPyr(.t.), NMor(*), DBNA(+) and NPip .(-) 
to acetylcholinesterase-by equilibrium dialysis 
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4.1.2 RESULTS (Contd.) 
TABLE 3 : Binding Constants calcu/aled from Seatchard plots of nitrosamines to acetylcholinesterase, as 
detennined by equilibrium dialysis experiments. 
LIGAND Kd(mH) P 
DPhNA 0.62 4.1 
MNGly 0.71 4.1 
DMNA 0.80 4.0 
DEtNA 0.91 4.1 
DENA 1.06 4.1 
DPNA 1.22 4.1 
NPyr 1.67 4.1 
NMor 2.02 4.0 
DBNA 2.83 4.0 
NPip 4. 21 4.0 
4.1.3 DISCUSSION 
The results show that the extent of binding of the nitrosamine 
to the enzyme depends on the size and shape of that molecule [APPENDIX 
12] . The Scatchard ana lysis of the results [FIGURES l1(a) and l1(b)] show that 
the enzyme contains a single class of binding sites. TABLE 3 shows the 
dissociation constants of various nitrosamine; which increase with an 
increase in the size of the alkyl groups attached to the nitroso group. 
The heterocyclic morpho line is a weakly polarised molecule due to the 
lone pair of electrons on the oxygen inside the ring, as such it is a 
weak nucleophile. Though the molecule is able to solvate the cations 
within its environment, its high dissociation constant (Kd=2.02mM) shows 
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that it binds less strongly to the active site of the enzyme. The 
IIIOlecule is relatively bulky compared to the other compounds studied. 
Upon the generation of an in situ quaternary nitrogen, the size of this 
compound prevents an effective interaction between the molecule and the 
active site. Another point is that on photodecomposition, NMor is 
expected to generate a 4-carbon a lkylating species, meaning that the 
longer alkyl group could effect a lower binding to the subsite of the 
enzyme. 
On the other hand, diethanolnitrosamine bears two hydroxyl groups which 
also make the molecule polar. These two functional groups are able to 
form hydrogen bonds with suitable groups in or around the active site of 
the enzyme. Its dissociat ion constant (Kd=O.91mM) reflects a stronger 
binding as compared to NMor. The length of the alkyl groups could 
disorientate the molecule around the active site, thus resulting in a 
far less stronger binding as compared to a tighter binding of 
diphenylnitrosamine (Kd=O.62mM). 
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4.2 GEL CHROMATOGRAPHY 
4.2.1 MATERIALS and METHODS 
4.2.1.1 Materials 
All the chemical reagents used were of analytical grade. 
Sephacryl-S 400 was obtained from Pharmac;a, and Bovine Serum Albumin 
(BSA) was from Sigma Chemicals Co. 
4.2.1.2 Methods 
The binding of the nitrosamine to the enzyme was studied 
, 
on the column (2x20cm) of Sephacryl-S 400, pre-equilibrated in phosphate 
(0.10mM, pH 7). The reaction mixture (3 ml) which contained the enzyme 
solution (O.l1mM, 1.0ml) and ligand (1.5-7.5mM) were applied to the 
column after being incubated at room temperature for 10 minutes. The 
flow rate of elution was 0.85ml.min-1 and the effluent was monitored at 
280nm. Data was ana lysed according to Scatchard. The number of the 
binding sites (p) and the dissoc;ation constant (Kd) of the enzyme-
ligand complex were determined according to equations (1) and (2) 
(PAGE 36). 
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FIGURE 12 :Elution chromatograph of absorbance change on binding of dibutylnitrosamine to 
acetylcholinesterase (O.l1mM) in O.lOmM phosphate buffer (PH 7.0)· The eluant was monitored at280nm 
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4.2.2 RESULTS (Contd.) 
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FIGURE 13 :Scatchard plot for binding of DPhNA(o). MNGly~. DMNA~. DEtNAfl) and DENA(x) to 
acetylcholinesterase as detennined by gel chromatography. "II are molecules of bound ligand. 
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4.2.2 RESULTS (Contd.) 
TABLE 4!Binding constants of AChE·Nitrosamine complexes determined from the corresponding 
Scatchard plot (FIGURE 13), using gel chromatography 
LIGAND Kd(mM) P 
DPhNA 0.68 3.90 
MNGly 0.80 3.93 
DMNA 0.87 3.89 
DEtNA 0.92 3.89 
DENA 1.01 4.00 
DPNA 1.25 3.82 
NPyr 1.72 3.79 
NMor 2.25 3.68 
DBNA 2.92 3.76 
NPip 4.60 3.83 
4.2.3 DISCUSSION 
The results obtained from Gel Chromatography indicate the same 
general pattern as those obtained from Equilibrium dialysis experiments. 
The dissociation of the enzyme-ligand complex ap~ea1Sto increase with an 
increase in the alkyl groups. DMNA(0.87mM), DENA(I.0ImM), DPNA(I.25mM) 
and DBNA(2.92mM). This pattern holds true for the cyclic ones! NPyr(I.72mM), 
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NPip(4.60mM). As before, DPhNA(0.68mM) with its lowest Kd value reflects 
the strongest binding of the rest of the group . 
4.3 FLUOROMETRIC EXPERIMENTS 
In recent years, Fluorescence Spectroscopy has been developed into 
a routine experimental procedure for the study of protein-ligand 
interactions (123,126,127). 
4.3.1 MATERIALS and METHODS 
4.3.1.1 Materials 
All the chemicals used were of analytical grade. 
4.3.1.2 Methods 
Titration measurements were made with Hitachi Fluoresence 
Spectrophotometer using an excitation light source from a Xenon-150 
lamp; fluorescence was measured through a cell at an angle of 900 to the 
incident beam. All the experiments were carried out at 200 C in phosphate 
buffer (O.lM, pH 7.2). The binding studies were carried out with 
nitrosamines (0-7.5mM), which were added to the enzyme solution 
(15.2Omg.ml-1). The mixture was excited at 285nm and analysed · at 330nm. 
Corrections for .inner filter effects were made according to procedure 
described by Helene u~. (128), equation (3): 
F/F1 = C = AT(1-10-Ao) / Ao(1-10-Ao ) ..•.. (3) 
where F1 is the observed fluorescence before application of the 
correction factor for inner filter effects, Ao is the absorbance of the 
acceptor a lone and AT is the tota 1 absorbance of the acceptor- li gand 
mixture. The corrected fluorescence intensities were used to determine 
the dissociation constants according to equations (4) and (5): 
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Kd I 1-9 = [L]t I 9-p[A]t ..•• (4) 9 = 6F I 6Fmax •... (5) 
where [A]t is the total concentration of the acceptor, i.e the enzyme in 
the system, p is the total number of binding sites, 9 is the fractional 
occupancy of the total acceptor sites by ligand,6Fmax is the increase in 
fluorescence at full saturation with ligand, 6 F is the increase in 
fluorescence of a known amount of ligand and [L]t is the total 
concentration of ligand. 
4.3.2 RESULTS 
10 
8 
,.., 
I 6 0 
-
)( 
.... 
~ 
"-
- 4 x 
IllF 
max 
2 
x x x 
0r------r------r------r------.-----~----~ 
1 2 3 4 6 7 
1 I [ L J,.(mH-1) 
FIGURE 14{a) : Double-reciprocal plots of fluorescence change on binding of DPhNA~), MNGly(o), 
DMNA (t), DEtNA (o),and DENA (x) to acetylcholinesterase (15.2Omg.mrl ) in O.lOM phosphate buffer 
pH 7.2). The mixture was excited at 285nm and emission measured at 33Onm. 
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FIGURE 14(b) :Double-reciprocal plots offluorescence change on binding of DPNA(e), NPyr(j), NMorfM 
DBNA(+) and NPip (~ to acetylcholinesterase (15.2Omg.mr1) in O.10M phosphate buffer (PH 7.2). The 
mixture was excited at 285nm and emission measured at 33Onm. 
47 
4.3.2 RESULTS (Contd.) 
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FIGURE lS(a) :Analysis data for the binding of DPhNA(<». MNGly(4). DMNA(_). DEtNA(o) and 
DENA{19 to acetylcholinuteras.e in O.10M phosphate buffer, pH 7.2. 
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FIGURE lS(b) :Analysis daJa for the binding of DPNA(e), NPyr(';, NMor(:t), DBNA(+) and NPip(fI) to 
acetylcholinesterase in O.10M phosphate buffer, pH 7.2 
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4.3.2 RESULTS (Contd.) 
TABLE 5 : Binding Constants caic;"laled from analysis data plots [FIGURES 15(a) and (b)] 
LIGAND Kd(mM) P 
DPhNA 0.65 4.0 
MNGly 0.75 3.9 
DMHA 0.88 4.1 
DEtHA 0.94 4.0 
DEHA 1.59 3.8 
DPHA 2.00 4.0 
NPyr 2.43 3.9 
HMor 2.86 4.2 
DBHA 3.44 4.0 
HPip 4.09 4.1 
4.3.3 DISCUSSION 
The analysis of these results show characteristic plots of 1/1-9 
versus [LIG.]/e to be linear, thus showing effect of these molecules on 
the enzyme [FIGS.14(a)-15(b)]. From these plots, the extent of 
dissociation of the AChE-ligand complex can be estimated. TABLE 5 shows 
the dissociation constants determined from the above figures. From these 
results, the nuniber of binding sites averages to 4, which was in good 
agreement to the other results from gel chromatography and equilibrium 
dialysis. There is an increase in the dissociation constants from 
DPhHA(0.65mH) to HPip(4.09mM). Again the same argument holds, that the 
aromatic nitrosamine DPhHA depicts a much tighter binding to the enzyme. 
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CHAPTERS DISCUSSION 
The chemical approach to biological problems through investigations of 
models rests upon the ability of the chosen system to mimic some 
functions of the biological ensemble. This then implies a full 
understanding of, amongst other things: the structure, localization and 
functions of a particular biological system under study. 
It was therefore the purpose of this project to synthesise a series of, 
secondary N-nitrosamines from their respective secondary amines; and to 
interact them with acetylcholinesterase, in order to study their effect 
on catalysis, their type of inhibition and their extent of binding to 
the active site of the enzyme. The choice of nitrosamines for this study 
is based on their established properties . The successful synthesis of 
these compounds by classical methods of nitrosation were carried out, 
for which good yields were recorded in their purified forms [TABLE 1]. 
The obtained melting and boiling points are comparable to the literature 
values. It could be established in this project that nitrosamines 
actually do affect catalysis of the enzyme as inhibitors in a reversible 
and competit ive way with respect to the substrate acetylthiocho 1 ine 
chloride (FIGURES 7-9(a». Kinetics results were analysed using standard 
graphical technique of Lineweaver and Burk (120). The lines were drawn 
by computer calculation for linear competitive inhibition (EQUATION 6): 
l/V = l/Vrnax [Km(l+I/Ki)].l/S + l/Vrnax .... (6) 
A replot of the slopes of double reciprocal plot versus ligand 
concentration are linear (FIGS.7 and 8, inset). The relevant kinetic 
parameters for the nitrosamines are presented [TABLE 2], where Km and 
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KmAPP are the respective Michaelis contants, Ki is the inhibitor 
constant of the enzyme-inhibitor complex calculated from equation (7) 
and from the extrapolation of the graph-slope versus nitrosamine 
concentration. According to this graph, the Ki should be 260 ~M, while 
Table 2 shows Ki is 60 ~M per subunit • 
KmAPP = Km{1+I/Ki) . . . • . . . . • (7) 
where I is the concentration of the particular nitrosamine. With 
variable substrate concentrations values for Km and Vmax for 
acetylcholinesterase were established as 102.61 ~M and 263.16 ~M.min-1 
respectively. 
The overall potency of a particular nitrosamine in the interaction of 
AChE could be established considering the dissociation and inhibitor 
constants. These values reflect the 'fit' of the nitrosamines into the 
active site of the enzyme. Such values depend on the size, configuration 
and the structure of such nitrosamines . Furthermore, the potency of the 
nitrosamine to bind non-covalently at or near to the active site plays a 
significant role. The more lipophilic or hydrophobic the nitrosamine, 
the less the ability to bind and inhibit the enzyme (54). As the length 
of the alkyl chain attached to the nitroso group increases so there is a 
decrease in activity of the enzyme. The kinetic data indicates an 
increase in the Ki values from DPhNA{20.32 ~M)fMNGly{30.18 ~M), DMNA 
(34.78 ~M), DEtNA{43.68 ~M), DENA{54.24 ~M), DPNA{60.36 ~M), NPyr 
(66.07 ~M), NMor{73.93 ~M), DBNA{95.54 ~M) and NPip{123.00 ~M). These 
values show that the aromatic DPhNA is a far more potent inhibitor than 
the other nitrosamines. 
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From the well established properties of nitrosamines, one can appreciate 
that the nitroso group [-N=O] of the nitrosamine resembles the carbonyl 
group [-C=O] of acetylcholine. By the same lati:tude of reasoning, the 
nitroso group interacts with the activated serine hydroxyl to form 
an eight-membered enzyme-inhibitor complex . Furthermore, perhaps a more 
acceptable reasoning is that an m rim quaternary nitrogen is developed 
[SCHEME 8 and APPENDIX 12]: 
SCHEME 8: The illuslTation of quaternary nitrogen anticipated to be generated in, or m the vicmiJy of the 
active rite of acetylcholmesterase, m situ. 
This quaternary nitrogen may then interact with the nucleophilic serine 
hydroxyl or the anionic subsite that is in close proximity (54),[SCHEME 
8]. The canonical form of the nitrosamine once bound could be expected 
to prevent the access of acetylthiocholine to the active site thereby 
competitively inhibiting the enzyme [SCHEMES 7 and 9]· 
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SCHEME 9 :llluslTation of competitive mhibition of AOJE by a quaternary form of a nitrosamme 
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Fundamentally, two properties for the binding of the nitrosamines to the 
active site of the enzyme could be implied (54): First, one protonated 
residue in the active site of the enzyme allows the formation of the 
enzyme-substrate complex. Secondly, the AChE active site must be 
hydrophobic in nature, and have at least one tryptophan residue (63). 
This means that when a nitrosamine binds to the enzyme, the former ought 
to pass from a hydrophilic to a hydrophobic environment, which has 
already been implicated as an important factor in enzyme catalysis. 
NHrosamines as rich sources of carbocations are able to alkylate the 
active site. The alkylating species [R+], [APPENDIX 13] label the 
carboxylate anion of the anionic subsite, consequently enhancing the 
coapetitive nature of the inhibition. The inhibition of the enzyme by 
these alkylating species is postulated to occur according to mechanism 
shown in [SCHEME 6] . The calculated inhibitor constants reflect the 
ease of transition between the hydrophilic and the hydrophobic 
environment due to the overall stability, energy as well as size of the 
carbocations and the intermediates. 
A general discussion of the Ki values for each nitrosamine is relevant 
at this stage. This will help the reader to understand the degree to 
which individual nitrosamine binds to the active site of the enzyme. 
This diversHy in va lues should be due to the different forms of 
structures and sizes that each nitrosamine assumes. 
The lowest Ki value is obtained for DPhNA(20.32 ~). This indicates 
that the nitrosamine has high potency as well as strong inhibitory 
ability on the enzyme. This can be explained by the fact that the two 
benzyl rings found in the aromatic diphenylnitrosamine at least do 
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appear to be highly stable in generating the corresponding intermediates 
[Ph-N+=N] and [Ph+]. The generation of a [Ph+] appears very unlikely. 
This leaves one with the conclusion that this high inhibition could be 
due to the in situ quaternary nitrogen developed within the nitrosamine 
JIIOlecule, after binding to the active site. The excessive electron 
density in the aromatic rings stabilise this positively charged nitrogen, 
thus influencing stronger interaction with anionic subsite of the enzyme 
causing a potent competitive inhibition. This is analogous to the 
situation of acetylcholine and for the quaternary ammonium salts binding 
to the enzyme. 
Other phenyl-derivative inhibitors however such as phenyltrialkyl 
ammonium salts were found' to be potent inhibitors of the enzyme. They 
have been reported to bind much tigher to the enzyme than the natural 
substrate (54). Therefore, if OPhNA decomposes into a diazonium 
intermediate [Ph-N+=N] and/or [Ph+]' then these intermediates would 
still effect ionic interaction at the anionic subsite. 
The Ki values increase from MNGly (30.18 ~M) to NPip (123.0 ~M). From 
SCHEME 6 showing the generation of carbocations, a short description 
concerning the potency of individual nitrosamines could be made. MNGly 
with its carboxylic acid group as a polar functional group is able to 
form hydrogen bond with other carboxylic groups in the active site or in 
the vicinity of the latter. This bond could result in the nitrosamine 
being less potent than DPhNA and generating much stronger inhibition 
than the rest of the other nitrosamines studied. On the other hand, 
DEtNA (Ki=43.68 ~M) has a hydrophilic hydroxyl group which is also 
polar, as well as the lipophilic or hydrophobic ethyl group. 
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Though the hydroxyl group is able to enter into hydrogen bond formation 
with suitable groups on the enzyme e.g serinyl hydroxyl, the 
effectiveness of such a bond is counteracted by the overall effect of 
the lipophilic ethyl groups. DENA(Ki=54.24 fLM}, DPNA(Ki=60.36 fLM} and 
NPyr(Ki=66.07fL M} upon decomposing into carbocations are expected to 
generate a two, three and four carbon alkylating species respectively. 
The results advance a logical explanation that the inhibition in these 
studies cannot only be intepreted in terms of the shape and conformation 
of the molecules, but the size of the alkyl groups as well. NMor 
(Ki=73.93 fLM) shows a very weak polarity and hence a weak 
nucleophilicity. Though the oxygen with its unshared electrons is able 
to solvate cations within its environment, it remains a less potent 
inhibitor of the enzyme . This could be attributed to the length of the 
alkyl groups it possesses . DBNA (Ki=95.54 fLM) and NPip (Ki=123.0 fLM) 
show even a lower degree of inhibition . This, according to Whiteley et at 
(54) points out that the more lipophilic the nitrosamine, the less the 
ability of binding and inhibition of the enzyme. 
Though nitrosamine carbocations can label the carboxylate moiety of the 
enzyme, this labelling may not necessarily and exclusively be limited to 
this subsite. Upon decomposition of the nitrosamine, the alkylating 
species could either alkylate other amino acids in a non-specific 
manner. Mechanism of inhibition [SCHEME 7]. shows that the alkylating 
species inhibit acetylcholinesterase in a competitive and irreversible 
way. The extent of inhibition is attributed to the number as well as the 
length of the carbocation generated . According to APPENDIX 13, each 
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dialkylnitrosamine will generate a pair of carbocation species: 
dimethylnitrosamine diethylnitrosamine 
dipropylnitrosamine [CH3CH2CH2+] and dibutylnitrosamine [CH3CH2CH2CH2+]. 
Logically, one of these species will interact covalently with the serine 
hydroxyl, imparting an irreversible inhibition on the enzyme. 
Furthermore, the remaining species may be trapped by reaction medium 
to afford the corresponding alcohol according to reaction (4): 
R+ + OW_ R-OH . . . • • . • . . •. (4) 
This reaction depends on the rate of decomposition of the nitrosamine, 
the proximity of such species to the active site as well as the actual 
conformation of the enzyme at that point in time. In the process of 
decomposition to yield the carbocation species, the rate-limiting step 
of mechanism should be the dissociation of the C-N bond in the 
nitrosamine. It must further be stated that the binding of nitrosamine 
to the enzyme forming a complex is influenced by the solvating 
properties of the catalytic site (54). The rate at which this process 
proceeds can be attributed to a change of solvating conditions in the 
active site, resulting from the binding of the nitrosamine with the 
enzyme esteratic site. 
On the other hand, diethanolnitrosamine generates two [HOCH2CH2+]. One 
of these species is anticipated to interact with the active site. In 
this case, the other species is not anticipated to be trapped by the 
medium to afford an alcohol. Instead, it can bind elsewhere on the 
enzyme either within the active site, or in its proximity. 
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Methylnitrosoglycine will generate two carbocations [CH3+] and 
[HOOCCH2+] according to their order of formation. During interaction 
with the enzyme, [CH3+] is able to interact covalently with the active 
site and also be trapped by the medium whereby it will form methanol. On 
The other hand, [HOOCH2+] is able to covalently bind to the active site 
but cannot afford an alcohol. 
The cyclic nitrosopyrrolidine, nitrosopiperidine and nitrosomorpholine, 
generate species that are positively charged on both ends: NPyr 
[CH2+CH2CH2CH2+], NPip [CH2+CH2CH2CH2CH2+] and NMor [CH2+CH20CH2CH2+]. 
Electrostatic repulsion might results from the interaction of the two 
.ends of an individual nitrosamine, rendering a weaker binding and a less 
stonger inhibition. While it is possible to envisage the binding to the 
enzyme by one end, the other might trapped by the basic medium to form 
alcohol moiety. 
It is clear that, relative to the environment of the binding site, the 
nitrosamines cannot increase the basicity of this environment during the 
generation of an alkylating species. An assumption is that the 
rearrangement could involve a conformational change in the enzyme 
molecule, leading to the exposure of some new basic groups inside the 
active site. 
It was also the aim of this project to study the extent of binding of 
these molecules to the active site of the enzyme. This was accomplished 
by Jll!ans of Equilibrium dialysis, Gel Chromatography and Fluorimetric 
titrations. The results of these three techniques show a similar trend 
[APPENDIX 11]. The analyses of such results indicate that the enzyme 
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contained a single class of binding sites [FIGURES 11(a)-15(b)]. The 
dissociation constants of various nitrosamine-AChE complexes are 
presented [APPENDIX 11]. As observed in binding studies, an increase in 
the dissociation constants was shown from these three techniques. 
The kinetic and binding studies results show a similar trend. The values 
of the dissociation constants obtained from the three techniques 
[APPENDIX 11] are averaged:DPhNA(Ki=20.32 .... M, Kd=O.65mM)i MNGly 
(Ki=30.18 .... M,Kd=O.75mM)iDMNA(Ki=34.7~M,Kd=O.85mM)iDEtNA(Ki=43.68 .... M, 
Kd=O.92mM)i DENA(Ki=54 . 24 .... M, Kd=1.22mM)i DPNA(Ki=60.36 .... M, Kd=1.49mM)i 
NPyr(Ki=66.07 .... M, Kd=1.94mM)i NMor(Ki=73.93 .... M, Kd=2.38mM)i DBNA 
(Ki=95.54 .... M, Kd=3.06mM) and NPip(Ki=123 .... M, Kd=4.30mM). The smaller 
values in both the Ki and Kd values signify the extent of inhibition as 
well as binding of the nitrosamine at the active site of the eQzyme. 
The observed low values indicate stronger inhibition potency as well as 
a tighter binding of the corresponding ligand to ,the active site, while 
the higher values reflect the opposite. 
These results tend to support the idea that two discrete sites exist on 
the enzyme, and also provide evidence indicating that the binding sites 
could be independent and indistinguishable. The linearity of the 
Scatchard plots was used to determine the number of binding sites which 
averaged to four. 
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CHAPTER 6 SUMMARY 
Acetylcholinesterase is confirmed to be found in a number of organs. It 
has been shown to be associated primarily with excitable membranes, 
cholinergic synapses, and endplates of neuromuscular junctions. It is 
also found in a few non-neuronal cells like erythrocytes in ·whi ch its 
function is unclear. 
Its physiological role is to ensure that the nerve impulse is of a 
finite duration, by lowering the concentration of acetylcholine. 
Furthermore, subcellular fractionation and cytochemical studies show 
that the enzyme is closely associated with the surface membrane of the 
excitable cell . However, the precise relationship of acetylcholine-
sterase to the excitable membrane is not clearly understood, and various 
studies indicate that a significant portion of the enzyme is not tightly 
associated with the plasma membrane (54). 
A substantial amount of evidence concerning the structure, locations and 
function of the enzyme have been reported. Mechanisms by which AChE 
catalyses its reactions, and by the way such reactions are inhibited 
have been postulated. Kinetic studies in the presence of nitrosamines 
indicate their capacity as competitive and reversible inhibitors of the 
enzyme. It was further shown that with time secondary N-nitrosamines act 
as competitive irreversible covalent inhibitors. The in situ quaternary 
nitrogen developed in the vicinity of the active site facilitates a 
competitive and reversible inhibition, while the alkylating carbocation 
facilitates a competitive covalent and irreversible inhibition . 
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A study of the kinetics as well as changes in fluorescence observed upon 
their binding to the enzyme, may provide information on the basic 
principles of intracellular communication, and on the functional 
properties of integral membrane proteins. 
The facts that the reversible inhibition by the nitrosamines is 
ca.petitive, and the subsequent irreversible inactivation is essentially 
the same toward hydrolysis of acety1thiocholine, support the proposal 
that the active site may be more specifically characterised by these 
nitrosamines. 
Inhibition constants show that the size, the structure and the 
conformation of the molecule have influence on the extent of binding to 
the active site, consequently bearing an overall influence on 
inhibition. Binding studies also reveal to a certain extent the nature 
of binding , the number of binding sites and the degree of binding to 
the active site of enzyme. It becomes apparent from these results that 
the smaller methyl groups belonging to dimethylnitrosamine and 
methylnitrosoglycine would not be expected to interfere with the process 
of binding, while it is probable that the larger and bulky ligands 
induce a decrease in binding capacity. It can be pointed out that the 
generation of carbocations by the nitrosamines within or around the 
microenvironment of the enzyme, in the neighbourhood of the active site 
can be assumed to be a reality. Fluorometric titrations, steady state 
kinetics, equilibrium perturbations and ligand binding studies, all 
support the proposed models for nitrosamine binding to 
acetylcholinesterase as favourable candidates to mimic acetylcholine, 
the natural substrate of the enzyme. 
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CONCLUSION 
It is clear that the objectives of this project have been attained. The 
following points constitute the findings in this project: 
(a) nitrosamines could be synthesised in large, purified 
quantities following classical method of nitrosation. 
(b) inhibition of acetylcholinesterase by secondary N-
nitrosamines is twofold: competitive and reversible as 
well as covalent competitive and irreversible. 
(c) the size, shape and conformation of the inhibitor do 
influence the extent of inhibition and binding to 
the active site of the enzyme. 
(d) acetylcholinesterase has independent hinding sites. 
(e) the number of binding sites averaged to four 
In the final analysis, as a point of departure, it is well documented 
that the dialkyl nitrosamines are carcinogenic. This, therefore 
precludes them for use as medical drugs to mimic acetylcholine or to 
inhibit acetylcholinesterase. Hence on this score they cannot be of much 
value to the human society especially in pathological diseases like 
erythroblastosis, thallasaemia major and also haemolytic disease. 
However the case may be, LIFE NOT BEING A BED OF ROSES, MUST GO ON I 
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APPENDIX! 
MOLAR ABSORPTION COEFFICIENTS OF N-NITROSAMINES 
USED IN THE TEXT 
NITROSAMINE log c ~ max (om) 
DBNA 1.95 350 
DENA 1.95 350 
DEtNA 1.95 350 
DMNA 1.95 350 
DPNA 1.95 350 
DPhNA 3.88 290 
MNGly 2.00 346 
NPip 1.95 350 
NPyr 1.95 350 
NMor 1.95 350 
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APPENDIX 2 
IH-NMR(i) and IR(ii) SPECTRA OF DIETIlANOLNITROSAMINE 
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APPENDlX3 
lH-NMR(i) andIR(ii) SPECTRA OF DIBUTYLNITROSAMINE 
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APPENDIX 4 
IH-NMR(j) and IR(ii) SPECTRA OF N-NITROSOPYRROUDINE 
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APPENDIX 5 
IH-NMR(i) and IR(ii) SPECTRA OF N-NITROSOPIPERlDINE 
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APPENDIX 6 
IH-NMR(j) and IR(ii) SPECTRA OF N-METHYL-N-NITROSOGLYONE 
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APPENDIX 7 
IR SPECTRUM OF DIPHENYLNITROSAMINE 
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APPENDIX 8 
IH-NMR(i) and IR(ii) SPECTRA OF N-NITROSOMORPHOUNE 
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APPENDIX 9 
MEASUREMENTS FOLLOWED IN THEASSAY AND KINETIC STUDIES OF 
ACETYLCHOUNESTERASE 
PIPETTE SUCCESSIVELY INTO CUVETTE: 
Buffer (pH 8.0) O.lM 3.Oml 
ATCh Solution 0.02ml 
DTNB Solution 0.10ml 
Inhibitor O.Olml 
IncuboJe oJ 3IPc for 10 minutes 
Enzyme O.Olml 
CONC.IN ASSAY MIX. 
Phosphate 100mM 
Acetylthiocholine 
0.0 ILM,32 ILM,39 ILM, 
48 ILM,64 ILM,92 ILM, 
159 ILM,478 ILM 
DTNB ~15 ILM 
Buffer(pH7.2) 100mM 
. NaHC03 560 IL M 
Nitroso compounds 
0.0 ILM,32 ILM,64 ILM, 
130 ILM,160 ILM,320 ILM 
Vol. fraction 6.4 ILL 
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APPENDIX 10 
GENERALAND SIMPliFIED ILLUSTRATIONS OF CATALYTIC REACTION MECHANISM OF 
ACETYLCHOliNESTERASE 
H3C /CHz /0. 0 ~ 'CH 'I /+\ z \ 
H3C CH3 CH3 
, 
r--""""" N:···-H-O 
Anionic Site Esteratic Site 
Enzyme-Ser-OH 
o 
" . /' H~C-C-O-"-CH2CH,-N-(CH,l, 
• ~ HO-CH,-CH,-N-(CH,l, 
o 
II 
,Enzyme-Ser-O - C-CH 1 
Enzyme-Ser-OH 
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HlC /CHz ° 0" 
'\ 'CH/ "t 
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APPENDIX 11 
BINDING CONSTANTS DETERMINED FROM STUDIES 
USING FLUOROMETRIC 11TRA110NS, GEL 
CHROMATOGRAPHY AND EQUIUBRIUM DIALYSIS 
LIGAND EQUIL. DIALYS. GEL CHROM. FLUOR. TITR. 
Kd(dI) p Kd(DI) p Kd(mM) p 
DPhNA 0.62 4.1 0.68 3.90 0.65 4.0 
MNGly 0.71 4.1 0.80 3.93 0.75 3.9 
DMNA 0.80 4.0 0.87 3.89 0.88 4.1 
DEtNA 0.91 4.1 0.92 3.89 0.94 4.0 
DENA 1.06 4.1 1.01 4.00 1.59 3.8 
DPNA 1.22 4.1 1.25 3.82 2.00 4.0 
NPyr 1.67 4.1 1.72 3.79 2.43 3.9 
NMor 2.02 4.0 2.25 3.68 2.86 4.2 
DBNA 2.83 4.0 2.92 3.76 3.44 4.0 
NPip 4.21 4.0 4.60 3.83 4.09 4.1 
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APPENDIX 12 
MOLECULAR AND RESONANCE STRUCIVRES OF SECONDARY NITROSAMlNES 
1. 
2. 
3. 
4. 
5. 
SYNTHESISED AND USEDAS INHmITORS/UGANDS OF 
ACETYLCHOUNESTERASE 
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APPENDIX U (Contd.) 
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APPENDIX 13 
SIMPliFIED REACTIONS SHOWING GENERATION OF 
CARBOCATION ALKYLATING SPEOES FROM 
DIFFERENT N-NITROSAMINES 
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3. CH3(CHJ2 
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